CEACAM1 and neoplasm: TIGIT is highly expressed in lymphocytes of CRC tissues108, while CEACAM1, which is an inhibitory receptor for various immune cell subsets, is expressed on the surface of numerous types of tumor cells and is considered to be a specific biomarker associated with tumor progression, metastasis, and poor prognosis108.